Paclitaxel and Carboplatin With or Without Bevacizumab in Treating Patients With Stage II, Stage III, or Stage IV Ovarian Epithelial Cancer, Primary Peritoneal Cancer, or Fallopian Tube Cancer
National Cancer Institute (NCI)
National Cancer Institute (NCI)
National Cancer Institute (NCI)
National Cancer Institute (NCI)
National Cancer Institute (NCI)
National Cancer Institute (NCI)
National Cancer Institute (NCI)
National Cancer Institute (NCI)
National Cancer Institute (NCI)
BeOne Medicines
National Cancer Institute (NCI)
BeOne Medicines
St. Jude Children's Research Hospital
National Cancer Institute (NCI)
Janssen Research & Development, LLC
Novartis
Seagen Inc.
Genmab
Eastern Cooperative Oncology Group
AstraZeneca
Seagen Inc.
AstraZeneca
Eli Lilly and Company
Pfizer
BioNTech SE
AstraZeneca
Incyte Corporation
Hoffmann-La Roche
Charite University, Berlin, Germany
M.D. Anderson Cancer Center
Arcus Biosciences, Inc.
Akeso
MedSIR
M.D. Anderson Cancer Center
Bristol-Myers Squibb
AstraZeneca
M.D. Anderson Cancer Center
City of Hope Medical Center
National Cancer Institute (NCI)
Akeso
Eastern Cooperative Oncology Group
RemeGen Co., Ltd.
Akeso
National Cancer Institute (NCI)
University of Michigan Rogel Cancer Center
Genmab
Amgen
Genmab
Summit Therapeutics
AstraZeneca
Gilead Sciences